Identification of a homozygous deletion at 8p12-21 in a human prostate cancer xenograft

被引:0
|
作者
Van Alewijk, DC
Van Der Weiden, MM
Eussen, BJ
Van Den Andel-Thijssen, LD
Ehren-Van Eekelen, CC
König, JJ
Van Steenbrugge, GJ
Dinjens, WN
Trapman, J
机构
[1] Erasmus Univ, Dept Pathol, NL-3000 DR Rotterdam, Netherlands
[2] Erasmus Univ, Dept Clin Genet, NL-3000 DR Rotterdam, Netherlands
[3] Erasmus Univ, Dept Urol, NL-3000 DR Rotterdam, Netherlands
来源
GENES CHROMOSOMES & CANCER | 1999年 / 24卷 / 02期
关键词
D O I
10.1002/(SICI)1098-2264(199902)24:2<119::AID-GCC4>3.0.CO;2-6
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
One of the most frequent genetic abnormalities in prostate cancer is loss of the complete or part of the short arm of chromosome 8, indicating the localization of one or more tumor suppressor genes on this chromosomal arm. Using allelotyping, a frequently deleted region in prostate cancer in a genetic interval of approximately 17 cM between sequence tagged sites D8S87 and D8S133 at chromosome arm 8p12-21 was previously detected. A detailed physical map of this region is now available. Using known and novel polymorphic and nonpolymorphic sequence tagged sites in this interval, a search for homozygous deletions in DNAs from 14 prostate cancer-derived cell lines and xenografts was carried out. In DNA from xenograft PC133, the presence of a small homozygously deleted region of 730-1,320 kb was unambiguously established. At one site, the deletion disrupts the Werner syndrome gene. Data from allelotyping were confirmed and extended by fluorescence in situ hybridization analysis of PC133 chromosome spreads using centromere, YAC, and PAC chromosome 8 probes. (C) 1999 Wiley-Liss, Inc.
引用
收藏
页码:119 / 126
页数:8
相关论文
共 50 条
  • [41] Antitumour effect of electrochemotherapy with bleomycin on human prostate cancer xenograft
    Ueki, Tei-ichiro
    Uemura, Hiroji
    Nagashima, Yoji
    Ohta, Shinsuke
    Ishiguro, Hitoshi
    Kubota, Yoshinobu
    BJU INTERNATIONAL, 2008, 102 (10) : 1467 - 1471
  • [42] A novel 8 mb interstitial deletion of chromosome 8p12-p21.2
    Klopocki, E
    Fiebig, B
    Robinson, P
    Tönnies, H
    Erdogan, F
    Ropers, HH
    Mundlos, S
    Ullmann, R
    AMERICAN JOURNAL OF MEDICAL GENETICS PART A, 2006, 140A (08) : 873 - 877
  • [43] A preclinical xenograft model of prostate cancer using human tumors
    Lawrence, Mitchell G.
    Taylor, Renea A.
    Toivanen, Roxanne
    Pedersen, John
    Norden, Sam
    Pook, David W.
    Frydenberg, Mark
    Papargiris, Melissa M.
    Niranjan, Birunthi
    Richards, Michelle G.
    Wang, Hong
    Collins, Anne T.
    Maitland, Norman J.
    Risbridger, Gail P.
    NATURE PROTOCOLS, 2013, 8 (05) : 836 - 848
  • [44] A REGION OF HOMOZYGOUS DELETION ON CHROMOSOME 9P21-22 IN PRIMARY NASOPHARYNGEAL CARCINOMA
    HUANG, DP
    LO, KW
    VANHASSELT, CA
    WOO, JKS
    CHOI, PHK
    LEUNG, SF
    CHEUNG, ST
    CAIRNS, P
    SIDRANSKY, D
    LEE, JCK
    CANCER RESEARCH, 1994, 54 (15) : 4003 - 4006
  • [45] High frequency of deletion on chromosome 9p21 may harbor several tumor-suppressor genes in human prostate cancer
    Perinchery, G
    Bukurov, N
    Nakajima, K
    Chang, J
    Li, LC
    Dahiya, R
    INTERNATIONAL JOURNAL OF CANCER, 1999, 83 (05) : 610 - 614
  • [46] DELETION MAPPING OF CHROMOSOME 8P IN PROSTATE-CANCER BY FLUORESCENCE IN-SITU HYBRIDIZATION
    MATSUYAMA, H
    PAN, Y
    SKOOG, L
    TRIBUKAIT, B
    NAITO, K
    EKMAN, P
    LICHTER, P
    BERGERHEIM, USR
    ONCOGENE, 1994, 9 (10) : 3071 - 3076
  • [47] Genetic alteration of the β-catenin gene (CTNNB1) in human lung cancer and malignant mesothelioma and identification of a new 3p21.3 homozygous deletion
    Kikuo Shigemitsu
    Yoshitaka Sekido
    Noriyasu Usami
    Shoichi Mori
    Mitsuo Sato
    Yoshitsugu Horio
    Yoshinori Hasegawa
    Scott A Bader
    Adi F Gazdar
    John D Minna
    Toyoaki Hida
    Hiromu Yoshioka
    Munehisa Imaizumi
    Yuichi Ueda
    Masahide Takahashi
    Kaoru Shimokata
    Oncogene, 2001, 20 : 4249 - 4257
  • [48] Genetic alteration of the β-catenin gene (CTNNB1) in human lung cancer and malignant mesothelioma and identification of a new 3p21.3 homozygous deletion
    Shigemitsu, K
    Sekido, Y
    Usami, N
    Mori, S
    Sato, M
    Horio, Y
    Hasegawa, Y
    Bader, SA
    Gazdar, AF
    Minna, JD
    Hida, T
    Yoshioka, H
    Imaizumi, M
    Ueda, Y
    Takahashi, M
    Shimokata, K
    ONCOGENE, 2001, 20 (31) : 4249 - 4257
  • [49] Deletion of chromosome 11p15, p12, q22, q23-24 loci in human prostate cancer
    Dahiya, R
    McCarville, J
    Lee, C
    Hu, WX
    Kaur, G
    Carroll, P
    Deng, GR
    INTERNATIONAL JOURNAL OF CANCER, 1997, 72 (02) : 283 - 288
  • [50] A CANDIDATE TUMOR-SUPPRESSOR GENE INVOLVED IN HUMAN PROSTATE-CANCER IS LOCATED ON CHROMOSOME 8P12-]P21 BETWEEN D8S87 AND D8S133
    FABER, PW
    SLEDDENS, HFBM
    DINJENS, WNM
    VANROOIJ, HCJ
    VANDERWEIDEN, MM
    SCHROEDER, FH
    BOSMAN, FT
    TRAPMAN, J
    CYTOGENETICS AND CELL GENETICS, 1995, 68 (3-4): : 157 - 157